Your browser doesn't support javascript.
loading
Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia.
Maurillo, Luca; Buccisano, Francesco; Spagnoli, Alessandra; Voso, Maria Teresa; Fianchi, Luana; Papayannidis, Cristina; Gaidano, Gian Luca; Breccia, Massimo; Musto, Pellegrino; De Bellis, Eleonora; Del Principe, Maria Ilaria; Lunghi, Monia; Lessi, Federica; Martinelli, Giovanni; Venditti, Adriano.
Afiliación
  • Maurillo L; Division of Hematology, Tor Vergata Foundation Polyclinic, Viale Oxford 81, 00133, Rome, Italy. luca.maurillo@uniroma2.it.
  • Buccisano F; Division of Hematology, Tor Vergata Foundation Polyclinic, Viale Oxford 81, 00133, Rome, Italy.
  • Spagnoli A; Hematology, Department of Biomedicine e Prevention, Tor Vergata University, Rome, Italy.
  • Voso MT; Department of Public Health and Infectious Disease, La Sapienza University, Rome, Italy.
  • Fianchi L; Division of Hematology, Tor Vergata Foundation Polyclinic, Viale Oxford 81, 00133, Rome, Italy.
  • Papayannidis C; Hematology, Department of Biomedicine e Prevention, Tor Vergata University, Rome, Italy.
  • Gaidano GL; Hematology, "Sacro Cuore" Catholic University, Rome, Italy.
  • Breccia M; Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology "L. and A. Seràgnoli", University of Bologna, Bologna, Italy.
  • Musto P; Division of Hematology, Department of Translation Medicine, University of Eastern Piedmont, Novara, Italy.
  • De Bellis E; Division of Cellular Biotechnologies and Hematology, University Sapienza, Rome, Italy.
  • Del Principe MI; Scientific Direction, Referral Cancer Center of Basilicata, IRCCS-CROB, Scientific Institute of Research and Cure, Rionero in Vulture, Italy.
  • Lunghi M; Division of Hematology, Tor Vergata Foundation Polyclinic, Viale Oxford 81, 00133, Rome, Italy.
  • Lessi F; Division of Hematology, Tor Vergata Foundation Polyclinic, Viale Oxford 81, 00133, Rome, Italy.
  • Martinelli G; Hematology, Department of Biomedicine e Prevention, Tor Vergata University, Rome, Italy.
  • Venditti A; Division of Hematology, Department of Translation Medicine, University of Eastern Piedmont, Novara, Italy.
Ann Hematol ; 97(10): 1767-1774, 2018 Oct.
Article en En | MEDLINE | ID: mdl-29947973

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Azacitidina / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Antimetabolitos Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Azacitidina / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Antimetabolitos Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Alemania